Medical and surgical approaches to pulmonary hypertension

Comprehensive Therapy

Volumn 23, Issue 9, 1997, Pages 612-616

  Mclaughlin, Vallerie V ^a   Rich, Stuart ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; PROSTACYCLIN; WARFARIN;

ARTICLE; CLINICAL TRIAL; COLLAGEN DISEASE; CONGENITAL HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART LUNG TRANSPLANTATION; HUMAN; LUNG DISEASE; LUNG EMBOLISM; LUNG TRANSPLANTATION; MITRAL VALVE DISEASE; OXYGEN THERAPY; PULMONARY HYPERTENSION; SURVIVAL; THROMBOEMBOLISM; VASCULAR DISEASE;

ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; EPOPROSTENOL; HEART-LUNG TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; THROMBOEMBOLISM;

EID: 0030883751     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Rich S, Dantzker RS, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med. 1987;107:216-223.
2. Abenhaim L, Maride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996;335:609-616.
3. Rubin LJ, Barst RJ, Kaiser LR, et al. Primary pulmonary hypertension. Chest 1993;104:206-250.
4. Edwards BS, Weir EK, Edwards WD, et al. Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol. 1987;10:1233-1238
5. Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension in HIV infection. Chest. 1991;100: 1268-1271.
6. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992;327:76-81.
7. Rich S, Brundage BH. High-dose calcium channel blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation. 1987;76:135-141.
8. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol prostacyclin with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996;334:296-301.
9. Valentini VV, Seidlitz M, Dodon E, et al. Acute effects of digoxin on hemodynamics, neurohormones, and baroreceptor response in pulmonary hypertension. Circulation. 1996; 94:I-23.
10. Nelson DM, Main E, Crafford W, Ahumada GG. Peripartum heart failure due to primary pulmonary hypertension. Obstet Gynecol. 1983;62(suppl):585-635.
11. Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982;306:557.
12. Kaiser LR, Cooper JD. The current status of lung transplantation. Adv Surg. 1992;25:259.
13. Kshettry VR, Kroshus TJ, Savik K, Hertz MI, Bolman RM. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients. Chest. 1996;110:704-709.
14. Rich S, Levitsky S, Brundage BH. Pulmonary hypertension from chronic pulmonary thromboembolism. Ann Intern Med. 1988;108:425-434.
15. Moser KM, Daily PO, Peterson K, et al. Thromboembolic pulmonary hypertension. Ann Intern Med. 1987;107:560-564.
16. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxic chronic obstructive airways disease? Ann Intern Med. 1980;93:391-398.
17. Salerni R, Rodnan GP, Leon DF, Shaver JA. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med. 1977;86: 394-399.
18. Dalen JE, Matloff JM, Evans GL, et al. Early reduction of pulmonary vascular resistance after mitral valve replacement. N Engl J Med. 1967;277:387-394.
19. Alexopoulos D, Lazzam C, Borrica S, et al. Isolated chronic mitral regurgitation with preserved systolic left ventricular function and severe pulmonary hypertension. J Am Coll Cardiol. 1989;14:319-322
20. Haworth ST. Pulmonary vascular disease in different types of congential heart disease: implications for interpretation of lung biopsy findings in early childhood. Br Heart J. 1984;52: 557-571.
21. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J. 1958;2:755-762.